Tankyrase inhibition demonstrates anti-fibrotic effects in preclinical pulmonary fibrosis models
Shoshy Alam Brinch, Ida Johnsen, Lena Willmer…·Jo Waaler
This study shows that the TNKS inhibitor OM-153 reduces fibrosis markers and ECM expression in multiple preclinical IPF models by inhibiting WNT/β-catenin and YAP signaling.